Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Niko, Järveläinen"'
Autor:
Jaakko Lampela, Juho Pajula, Niko Järveläinen, Satu Siimes, Nihay Laham-Karam, Antti Kivelä, Isidore Mushimiyimana, Jussi Nurro, Juha Hartikainen, Seppo Ylä-Herttuala
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Heart failure (HF) is a major burden worldwide, and new therapies are urgently needed. Gene therapy is a promising new approach to treat myocardial diseases. However, current cardiac gene delivery methods for producing global myocardial effe
Externí odkaz:
https://doaj.org/article/e1082cb239494cd496817d852e1222e7
Publikováno v:
Journal of Visualized Experiments.
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2573
NOGA/MyoStar system uses low magnetic fields and endomyocardial electrical parameters, allowing precise endomyocardial injections of therapeutic agents to ischemic yet viable myocardium which is most likely to respond to the treatment. Preclinical an
Publikováno v:
Methods in Molecular Biology ISBN: 9781071627068
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30f932041804487896ad8a8db565850d
https://doi.org/10.1007/978-1-0716-2707-5_14
https://doi.org/10.1007/978-1-0716-2707-5_14
Autor:
Henna Korpela, Jaakko Lampela, Jonna Airaksinen, Niko Järveläinen, Satu Siimes, Kaisa Valli, Tiina Nieminen, Minttu Turunen, Maria Grönman, Antti Saraste, Juhani Knuuti, Mikko Hakulinen, Pekka Poutiainen, Vesa Kärjä, Jussi Nurro, Seppo Ylä-Herttuala
Publikováno v:
Gene Therapy
Therapeutic angiogenesis induced by gene therapy is a promising approach to treat patients suffering from severe coronary artery disease. In small experimental animals, adeno-associated viruses (AAVs) have shown good transduction efficacy and long-te
Autor:
Paavo Halonen, Petri I. Mäkinen, Henna Korpela, Seppo Ylä-Herttuala, Niko Järveläinen, Olli-Pekka Hätinen, Li-Ming Gan, Jussi Nurro, Regina Fritsche-Danielson
Publikováno v:
Human gene therapy. 32(19-20)
Based on recent success in using modified RNA in clinical applications, we tested the safety, feasibility, and efficacy of direct delivery of citrate-saline-formulated mRNA into an hibernating ischemic heart muscle using an electromechanical mapping